Oncosec Medical (ONCS) Announces Preclinical Data Show Multi-Gene Expression Platform for Delivery of Multiple Cancer Immunotherapies at SITC
Tweet Send to a Friend
OncoSec Medical Incorporated (NASDAQ: ONCS), a company developing DNA-based cancer immunotherapies, will present emerging data from its novel, multi-gene ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
